Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul 13:8:706277.
doi: 10.3389/fmolb.2021.706277. eCollection 2021.

Editorial: Bioengineered Nanoparticles in Cancer Therapy

Affiliations
Editorial

Editorial: Bioengineered Nanoparticles in Cancer Therapy

Payam Zarrintaj et al. Front Mol Biosci. .
No abstract available

Keywords: bioengineering; biomaterials; cancer therapy; nanoparticles; nanotechnology.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research TopicBioengineered Nanoparticles in Cancer Therapy

References

    1. Chauhan V. P., Jain R. K. (2013). Strategies for Advancing Cancer Nanomedicine. Nat. Mater 12, 958–962. 10.1038/nmat3792 - DOI - PMC - PubMed
    1. Gutiérrez T. J., Alvarez V. A. (2018). “Nanoparticles for Hyperthermia Applications,” in Handbook of Nanomaterials for Industrial Applications: Micro and Nano Technologies. Editor Hussain C. M. (EE.UU: Elsevier; ), 563–576. 10.1016/b978-0-12-813351-4.00032-8 - DOI
    1. Gutiérrez T. J. (2018). “Biocomposites for Hyperthermia Applications,” in Biocomposites: Biomedical and Environmental Applications. Editors Ahmed S., Ikram S., Kanchi S., Bisetty K. (Singapore: Pan Stanford Publishing; ), 97–134. 10.1201/9781315110806-4 - DOI
    1. Khodadadi Yazdi M., Taghizadeh A., Taghizadeh M., Stadler F. J., Farokhi M., Mottaghitalab F., et al. (2020). Agarose-based Biomaterials for Advanced Drug Delivery. J. Controlled Release 326, 523–543. 10.1016/j.jconrel.2020.07.028 - DOI - PubMed
    1. Shi J., Kantoff P. W., Wooster R., Farokhzad O. C. (2017). Cancer Nanomedicine: Progress, Challenges and Opportunities. Nat. Rev. Cancer 17, 20–37. 10.1038/nrc.2016.108 - DOI - PMC - PubMed

Publication types

LinkOut - more resources